Dnaprint Genomics Stock Volatility
DNAPrint Genomics is out of control given 3 months investment horizon. DNAPrint Genomics retains Efficiency (Sharpe Ratio) of 0.13, which denotes the company had a 0.13 % return per unit of risk over the last 3 months. We were able to analyze twelve different technical indicators, which can help you to evaluate if expected returns of 16.39% are justified by taking the suggested risk. Use DNAPrint Genomics Standard Deviation of 128.04, market risk adjusted performance of 0.3315, and Variance of 16393.44 to evaluate company specific risk that cannot be diversified away.
Sharpe Ratio = 0.128
| High Returns | Best Equity | DNAG | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average DNAPrint Genomics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DNAPrint Genomics by adding it to a well-diversified portfolio.
Key indicators related to DNAPrint Genomics' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
DNAPrint Genomics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of DNAPrint daily returns, and it is calculated using variance and standard deviation. We also use DNAPrint's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of DNAPrint Genomics volatility.
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as DNAPrint Genomics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of DNAPrint Genomics at lower prices to lower their average cost per share. Similarly, when the prices of DNAPrint Genomics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities. Main indicators related to DNAPrint Genomics' market risk premium analysis include:
Beta 50.96 | Alpha 11.62 | Risk 128.04 | Sharpe Ratio 0.13 | Expected Return 16.39 |
Moving together with DNAPrint Stock
Moving against DNAPrint Stock
| 0.44 | DSGN | Design Therapeutics | PairCorr |
| 0.37 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.36 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.34 | 63E | ONWARD MEDICAL BV | PairCorr |
DNAPrint Genomics Market Sensitivity And Downside Risk
DNAPrint Genomics' beta coefficient measures the volatility of DNAPrint stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents DNAPrint stock's returns against your selected market. In other words, DNAPrint Genomics's beta of 50.96 provides an investor with an approximation of how much risk DNAPrint Genomics stock can potentially add to one of your existing portfolios. DNAPrint Genomics is displaying above-average volatility over the selected time horizon. You can indeed make money on DNAPrint instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze DNAPrint Genomics Demand TrendCheck current 90 days DNAPrint Genomics correlation with market (Dow Jones Industrial)DNAPrint Genomics Volatility and Downside Risk
DNAPrint standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
DNAPrint Genomics Stock Volatility Analysis
Volatility refers to the frequency at which DNAPrint Genomics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with DNAPrint Genomics' price changes. Investors will then calculate the volatility of DNAPrint Genomics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of DNAPrint Genomics' volatility:
Historical Volatility
This type of stock volatility measures DNAPrint Genomics' fluctuations based on previous trends. It's commonly used to predict DNAPrint Genomics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for DNAPrint Genomics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on DNAPrint Genomics' to be redeemed at a future date.Transformation |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. DNAPrint Genomics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
DNAPrint Genomics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 50.9603 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, DNAPrint Genomics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to DNAPrint Genomics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that DNAPrint Genomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a DNAPrint stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Predicted Return Density |
| Returns |
What Drives a DNAPrint Genomics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.DNAPrint Genomics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of DNAPrint Genomics is 781.02. The daily returns are distributed with a variance of 16393.44 and standard deviation of 128.04. The mean deviation of DNAPrint Genomics is currently at 32.25. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.79
α | Alpha over Dow Jones | 11.62 | |
β | Beta against Dow Jones | 50.96 | |
σ | Overall volatility | 128.04 | |
Ir | Information ratio | 0.13 |
DNAPrint Genomics Stock Return Volatility
DNAPrint Genomics historical daily return volatility represents how much of DNAPrint Genomics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 128.0369% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7778% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between DNAPrint Stock performing well and DNAPrint Genomics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DNAPrint Genomics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| USRM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| IPAH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| LADX | 31.31 | 13.68 | 0.00 | (1.51) | 0.00 | 9.09 | 1,009 | |||
| MOBO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| BRAXF | 3.03 | (1.56) | 0.00 | (12.76) | 0.00 | 0.00 | 92.31 | |||
| REFG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MRPI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| JNHMF | 26.22 | 12.56 | 0.00 | 1.63 | 0.00 | 0.00 | 800.00 | |||
| MHTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
About DNAPrint Genomics Volatility
Volatility is a rate at which the price of DNAPrint Genomics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of DNAPrint Genomics may increase or decrease. In other words, similar to DNAPrint's beta indicator, it measures the risk of DNAPrint Genomics and helps estimate the fluctuations that may happen in a short period of time. So if prices of DNAPrint Genomics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany. DNAPRINT GENOMICS is traded on OTC Exchange in the United States.
DNAPrint Genomics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on DNAPrint Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much DNAPrint Genomics' price varies over time.
3 ways to utilize DNAPrint Genomics' volatility to invest better
Higher DNAPrint Genomics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of DNAPrint Genomics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. DNAPrint Genomics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of DNAPrint Genomics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in DNAPrint Genomics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of DNAPrint Genomics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
DNAPrint Genomics Investment Opportunity
DNAPrint Genomics has a volatility of 128.04 and is 164.15 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of DNAPrint Genomics is higher than 96 percent of all global equities and portfolios over the last 90 days. You can use DNAPrint Genomics to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of DNAPrint Genomics to be traded at $0.0 in 90 days.Good diversification
The correlation between DNAPrint Genomics and DJI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DNAPrint Genomics and DJI in the same portfolio, assuming nothing else is changed.
DNAPrint Genomics Additional Risk Indicators
The analysis of DNAPrint Genomics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in DNAPrint Genomics' investment and either accepting that risk or mitigating it. Along with some common measures of DNAPrint Genomics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1114 | |||
| Market Risk Adjusted Performance | 0.3315 | |||
| Mean Deviation | 32.25 | |||
| Coefficient Of Variation | 781.02 | |||
| Standard Deviation | 128.04 | |||
| Variance | 16393.44 | |||
| Information Ratio | 0.1272 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
DNAPrint Genomics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against DNAPrint Genomics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. DNAPrint Genomics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, DNAPrint Genomics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to DNAPrint Genomics.
Complementary Tools for DNAPrint Stock analysis
When running DNAPrint Genomics' price analysis, check to measure DNAPrint Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNAPrint Genomics is operating at the current time. Most of DNAPrint Genomics' value examination focuses on studying past and present price action to predict the probability of DNAPrint Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNAPrint Genomics' price. Additionally, you may evaluate how the addition of DNAPrint Genomics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |